{"id":{"repo_id":"emich","oai_identifier":"oai:commons.emich.edu:theses-1850"},"canonical_url":"https://search.dev.ndltd.org/etd/emich/oai:commons.emich.edu:theses-1850","repository":{"repo_id":"emich","name":"Eastern Michigan University","base_url":"https://commons.emich.edu/do/oai/"},"display":{"title":"Perceptions of clinical research coordinators about the quality of monitoring and major failings/concerns in the monitoring process","abstract":"<p>The primary goals of clinical research monitoring are to assure adequate protection of the rights of human subjects, and the safety of all subjects involved in clinical investigations or clinical trials, and the quality and integrity of the data generated from clinical trials. Adequate monitoring of clinical trials can prevent the occurrence of significant problems, which may affect the entire process of bringing a new drug to market. The proper monitoring of clinical trials is a challenge. In spite of well established regulations and guidance, there remain many monitoring related concerns in clinical trials (e.g. protocol deviations and violations, IRB violations, improper adverse event reporting, etc). The survey results indicate that clinical research coordinators believe that there are concerns in the monitoring process, and that the quality of monitoring varies from monitor to monitor. Results also suggest that some monitors are exceptional, where as some monitors are abysmal.</p>","abstract_html":"&lt;p&gt;The primary goals of clinical research monitoring are to assure adequate protection of the rights of human subjects, and the safety of all subjects involved in clinical investigations or clinical trials, and the quality and integrity of the data generated from clinical trials. Adequate monitoring of clinical trials can prevent the occurrence of significant problems, which may affect the entire process of bringing a new drug to market. The proper monitoring of clinical trials is a challenge. In spite of well established regulations and guidance, there remain many monitoring related concerns in clinical trials (e.g. protocol deviations and violations, IRB violations, improper adverse event reporting, etc). The survey results indicate that clinical research coordinators believe that there are concerns in the monitoring process, and that the quality of monitoring varies from monitor to monitor. Results also suggest that some monitors are exceptional, where as some monitors are abysmal.&lt;/p&gt;","abstract_has_math":false,"creators":["Movva, Praveen Krishna"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Open Access Thesis","degree_discipline":"Health Sciences","degree_department":null,"school":null,"contributors":["Stephen A. Sonstein, PhD, Chair","Ronald F. Maio, D.O., MS","Irwin Martin, PhD"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-04-01T07:00:00Z","date_published":"2013-04-01T07:00:00Z","updated_at":"2026-07-24T02:16:51Z","subjects":["research","clinical trials","monitoring","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://commons.emich.edu/theses/479","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Stephen A. Sonstein, PhD, Chair","Ronald F. Maio, D.O., MS","Irwin Martin, PhD"]},{"key":"dc:creator","label":"Author","values":["Movva, Praveen Krishna"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2013-09-13T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Health Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["research","clinical trials","monitoring","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://commons.emich.edu/theses/479"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The primary goals of clinical research monitoring are to assure adequate protection of the rights of human subjects, and the safety of all subjects involved in clinical investigations or clinical trials, and the quality and integrity of the data generated from clinical trials. Adequate monitoring of clinical trials can prevent the occurrence of significant problems, which may affect the entire process of bringing a new drug to market. The proper monitoring of clinical trials is a challenge. In spite of well established regulations and guidance, there remain many monitoring related concerns in clinical trials (e.g. protocol deviations and violations, IRB violations, improper adverse event reporting, etc). The survey results indicate that clinical research coordinators believe that there are concerns in the monitoring process, and that the quality of monitoring varies from monitor to monitor. Results also suggest that some monitors are exceptional, where as some monitors are abysmal.</p>"]},{"key":"dc:title","label":"Title","values":["Perceptions of clinical research coordinators about the quality of monitoring and major failings/concerns in the monitoring process"]}]}],"canonical_facts":{"dc:contributor":["Stephen A. Sonstein, PhD, Chair","Ronald F. Maio, D.O., MS","Irwin Martin, PhD"],"dc:creator":["Movva, Praveen Krishna"],"dc:date.available":["2013-09-13T07:00:00Z"],"dc:description.abstract":["<p>The primary goals of clinical research monitoring are to assure adequate protection of the rights of human subjects, and the safety of all subjects involved in clinical investigations or clinical trials, and the quality and integrity of the data generated from clinical trials. Adequate monitoring of clinical trials can prevent the occurrence of significant problems, which may affect the entire process of bringing a new drug to market. The proper monitoring of clinical trials is a challenge. In spite of well established regulations and guidance, there remain many monitoring related concerns in clinical trials (e.g. protocol deviations and violations, IRB violations, improper adverse event reporting, etc). The survey results indicate that clinical research coordinators believe that there are concerns in the monitoring process, and that the quality of monitoring varies from monitor to monitor. Results also suggest that some monitors are exceptional, where as some monitors are abysmal.</p>"],"dc:identifier":["https://commons.emich.edu/theses/479"],"dc:subject":["research","clinical trials","monitoring","Medicine and Health Sciences"],"dc:title":["Perceptions of clinical research coordinators about the quality of monitoring and major failings/concerns in the monitoring process"],"thesis:degree_discipline":["Health Sciences"],"thesis:degree_level":["Open Access Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T02:16:51Z"}